Accessibility Menu
 
AtriCure logo

AtriCure

(NASDAQ) ATRC

Current Price$28.88
Market Cap$1.44B
Since IPO (2005)+105%
5 Year-54%
1 Year-16%
1 Month-7%

AtriCure Financials at a Glance

Market Cap

$1.44B

Revenue (TTM)

$534.53M

Net Income (TTM)

$11.45M

EPS (TTM)

$-0.24

P/E Ratio

-119.83

Dividend

$0.00

Beta (Volatility)

1.20 (Average)

Price

$28.88

Volume

14,685

Open

$30.10

Previous Close

$28.88

Daily Range

$28.84 - $30.10

52-Week Range

$28.29 - $43.18

ATRC: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About AtriCure

Industry

Healthcare Equipment and Supplies

Employees

1,350

CEO

Michael H. Carrel, MBA

Headquarters

Mason, OH 45040, US

ATRC Financials

Key Financial Metrics (TTM)

Gross Margin

75%

Operating Margin

-2%

Net Income Margin

-2%

Return on Equity

-2%

Return on Capital

-1%

Return on Assets

-2%

Earnings Yield

-0.83%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.44B

Shares Outstanding

49.81M

Volume

14.69K

Short Interest

0.00%

Avg. Volume

652.73K

Financials (TTM)

Gross Profit

$397.74M

Operating Income

$3.45M

EBITDA

$16.25M

Operating Cash Flow

$57.33M

Capital Expenditure

$9.05M

Free Cash Flow

$48.28M

Cash & ST Invst.

$167.43M

Total Debt

$88.02M

AtriCure Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$140.50M

+13.1%

Gross Profit

$104.58M

+12.9%

Gross Margin

74.43%

N/A

Market Cap

$1.44B

N/A

Market Cap/Employee

$1.11M

N/A

Employees

1,300

N/A

Net Income

$1.76M

+111.3%

EBITDA

$8.97M

+199.4%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$79.41M

+71.9%

Accounts Receivable

$66.65M

+10.5%

Inventory

$78.49M

+4.2%

Long Term Debt

$84.90M

+15.2%

Short Term Debt

$3.12M

+11.3%

Return on Assets

-1.75%

N/A

Return on Invested Capital

-1.48%

N/A

Free Cash Flow

$23.43M

+364.5%

Operating Cash Flow

$20.03M

+243.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IMCRImmunocore Holdings plc
$29.44-3.51%
NVCRNovoCure Limited
$10.97-6.72%
KMTSKestra Medical Technologies, Ltd.
$19.46-1.12%
QDELQuidelOrtho Corporation
$14.78-5.26%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$38.78-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.28+0.05%
QQQInvesco QQQ Trust
$562.58-0.02%
ARTLArtelo Biosciences
$10.54+2.30%

Questions About ATRC

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.